According to NICE guidelines (TA875), semaglutide is approved for weight management in the UK, specifically for individuals with a BMI over 30 with weight-related conditions, or over 35 without such conditions
52,60 However, it is unknown to the authors if the regenerative properties of nanofat are impacted by GLP-1 RAs, which could raise a concern regarding early use of this modality
Some participants may notice nausea for several days after starting or increasing a research dose, while others may experience symptoms for longer
G., Snchez, E., Romero, I., Vidal-Puig, A., Berral, F
Ye P, Cheah IK, Halliwell B (2013) A high-fat and cholesterol diet causes fatty liver in guinea pigs